Avails Medical, a Menlo Park, California diagnostics company, has secured an award worth up to $2.5 million from CARB-X to develop an electronic antibiotic susceptibility testing (AST) device.
The innovation would expedite healthcare providers’ ability to determine the most effective antibiotic treatment for serious and life-threatening blood infections via electronic biosensors fitting onto commercially available AST panels.
“Speed is a critical component of effectively diagnosing and treating serious antibiotic-resistant bacterial infections, including bloodstream infections,” Erin Duffy, chief of Research and Development of CARB-X, said.
CARB-X is a global non-profit partnership based at Boston University School of Law funding and supporting the development of new antibiotics, vaccines, diagnostics, and other products to address antibiotic-resistant bacteria.
The award is worth up to $2.5 million, plus up to $14.7 million more if the Avails project progresses successfully in later phases, subject to available funds.
“Currently, it can take days to identify which antibiotics are most effective to treat a lethal bacterial infection in the bloodstream,”
Oren Knopfmacher, CEO of Avails Medical, said. “The Avails eAST technology aims to provide phenotypic results within four hours from a positive blood culture sample, which is critical to guide antibiotic therapy decisions especially in multi-drug resistance infections.”
Researchers indicated the technology is easy-to-use and could be ideal for smaller community-based hospitals and clinics to expedite the delivery of information critical for treatment decisions.
With China in mind, U.S. Reps. Brad Wenstrup (R-OH) and Raja Krishnamoorthi (D-IL) recently introduced…
As part of an annual action known as the Money Mule Initiative, federal law enforcement…
In a recent letter to the Federal Transit Administration (FTA), Republicans from the House Transportation…
With approval from the House this week, the Fire Grants and Safety Act (S.870) seems…
The Cyber Safety Review Board (CSRB), which is only two years old, announced a shakeup…
Opposition rose this week against a proposal from the U.S. Air Force within the FY…
This website uses cookies.